Griffin Discoveries

Company name

Griffin Discoveries


VU University Amsterdam

The company

This spin-off company has a favorable basis for developing GPCR-targeting compounds which could be of particular interest to the pharmaceutical industry. Griffin Discoveries can offer pharmaceutical companies collaborations in various phases of development, in which they can obtain maximum benefit of Griffin’s two products: the innovative GPCR technology platform and GPCR-related IP.

Many pharmaceutical companies try to find novel hits for emerging drug targets by applying resource-intensive high-throughput screening (HTS) technologies. Griffin Discoveries  is able to design drugs based on the receptor’s structure. This method requires less capital and materials, and is more efficient than a HTS approach.